13 Fr: The Newest Addition to Our Agilis™ NxT Steerable Introducer Family
The market-leading Agilis NxT Steerable Introducer is now compatible with larger catheters to support all therapy deliveries from PFA to RF to CRYO - for an optimal workflow with our One System Solution. Introducing the Agilis NxT Steerable Introducer, Dual‑Reach™ (13 Fr).
Market-leading Agilis NxT Steerable Introducer now compatible with larger catheters with the introduction of Agilis NxT Steerable Introducer, Dual-Reach (13 Fr).
ATRAUMATIC TIP
New low-profile design and atraumatic tip
SIX OFF SET VENTING HOLES
Smaller diameter (.030”) and 90º offset reduces the likelihood of guidewire exiting through side holes
RADIO-OPAQUE TIP MARKER
Ring of platinum iridium enables visualization under fluoro; 4 mm from tip
SHEATH TO DILATOR FIT
Low-profile design with lower transeptal crossing force
BRAIDED SHAFT
Provides exceptional torquability, pushability and kink resistance with Dual-Reach™ bidirectional 180˚/90˚ deflection to allow asymmetric deflection for more mobility
BI-DIRECTIONAL; ROTATING COLLAR
To deflect the tip clockwise ≥180° and counterclockwise ≥90° auto locking
HEMOSTASIS VALVE
3-way stopcock for air or blood aspiration, fluid infusion, blood sampling
8.5 Fr: Choose the Gold Standard
As evidenced in more than one million procedures*, for a growing number of physicians, Agilis NxT Steerable Introducer (8.5 Fr) is the introducer of choice when guiding ablation catheters to treat arrhythmias. Tailor to your patient’s anatomy with a large variety of sizes and curves that maintain their shape
Curves shown is for 8.5 Fr Agilis NxT Steerable Introducer
Confident steering and stable positioning with exceptional maneuverability
Enhanced catheter stability enables control of tip movements within millimeters along the intended ablation line1
Access hard-to-reach areas with precise maneuverability and auto-lock steering, such as the right inferior and left anterior pulmonary veins1
Enhanced procedural efficiency with exceptional contact force.
Greater catheter-tissue contact force, which may support more durable lesion formation2
Reliable, Complete Lesion Creation Through Outstanding Agility and Stability
Greater freedom from arrhythmia at 6 months (76.0% vs 53.0%)3 and 18% greater at 12 months (74.0% vs 62.7%)4
Complete PVI isolation (left- and right-sided veins) (43 pts vs 8 pts)1
Fewer re-do ablations (6 pts vs 23 pts)1 and 17% fewer acute PV reconnections (50% vs 60%)5
This device is commercially available for use in select international markets.
*Based on sales through Dec 31, 2020
Information herein intended for distribution outside the U.S. only, excluding Finland.
References
- Piorkowski C, et al. (2008). Steerable sheath catheter navigation for ablation of atrial fibrillation: A case-control study. Pacing and Clinical Electrophysiology, 31(7), 863–873.
- Cuoco F, et al. (2014). Steerable sheath promotes improved contact force parameters during pulmonary vein isolation. Heart Rhythm, Vol. 11, No. 5, May Supplement.
- Piorkowski C, et al. (2011). Steerable versus non-steerable sheath technology in AF ablation: A prospective, randomized study. Circulation, 4(2), 157–165.
- Mansour M. (2014). TOCCASTAR: Preliminary Results of the First Prospective Randomized Study of a Contact Force Sensing Ablation Catheter for the Treatment of Paroxysmal AF. Presented at HRS AF Summit 2014. San Francisco, California.
- Hutchinson M, et al. (2013). Efforts to enhance catheter stability improve atrial fibrillation ablation outcome. Heart Rhythm, 10(3), 347–353.
MAT-2414395 v2.0